ZFP

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 14, 2023

The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By End use, By Region, And Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By End use, By Region, And Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.
  • The anticipated growth of the global Huntington's disease treatment market is poised to make a significant impact, with projections indicating it will reach a substantial USD 1,871.2 million by 2030, as detailed in this comprehensive report.
  • Huntington's disease, a rare inherited neurodegenerative condition, exerts its impact across multiple generations, severely affecting individuals between the ages of 30 and 50.
  • The symptomatic treatment segment accounted for the largest revenue share in 2022 owing to the product availability and patent protection.

Taste Club, a Luxury Concierge Dining & Travel Membership Club Showcasing Megastar Chefs to Launch May 2023

Retrieved on: 
Wednesday, May 17, 2023

LOS ANGELES, May 17, 2023 /PRNewswire/ -- Taste Club, a first-of-its-kind national dining & global luxury travel club supported by an internal, best-in-class concierge team, is poised to launch in May 2023. Benefiting nonprofits in the hospitality industry, and committed to championing independent restaurants, Taste Club is partnering with a Who's Who collection of celebrated chefs across the country. Memberships provide access to exclusive dining experiences curated for them by each of the celebrated chefs/restaurant partners. In addition, members will enjoy access to bespoke luxury travel experiences: a blending of effortless travel, transportation, insider access to premier events, stunning accommodations, and unforgettable culinary experiences. From the moment a membership is approved, members will have direct access to the Taste Club concierge platform to book their first dining or travel experience.

Key Points: 
  • Members receive preferred access to the most acclaimed restaurants in the country, exclusive tasting menus designed by celebrated chefs, and access to a collection of bespoke Taste Club Travel Experiences
    LOS ANGELES, May 17, 2023 /PRNewswire/ -- Taste Club, a first-of-its-kind national dining & global luxury travel club supported by an internal, best-in-class concierge team, is poised to launch in May 2023.
  • From the moment a membership is approved, members will have direct access to the Taste Club concierge platform to book their first dining or travel experience.
  • Today, Taste Club announced their 12 founding chef partners:
    Kopel and Taste Club have assembled a dream team of luxury travel experts to add unparalleled value to memberships.
  • Between Taste Club's Travel Tastemakers and in-house team, every event and travel experience will have a Taste Club representative on-site to ensure a seamless experience.

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report 2022-2030, Featuring Profiles of H. Lundbeck, Teva Pharmaceutical, Bausch Health Companies and Lupin - ResearchAndMarkets.com

Retrieved on: 
Friday, April 29, 2022

The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Symptomatic Treatment, Disease-Modifying Therapies), by Region and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Symptomatic Treatment, Disease-Modifying Therapies), by Region and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global Huntington's disease treatment market size is expected to reach USD 1.8 billion by 2030.
  • This growth is due to high R&D investments for new product development, research collaboration, and the high HD burden in western countries.
  • The symptomatic treatment segment accounted for the largest revenue share in 2021 owing to the product availability and patent protection.